Your search returned 37 results. Subscribe to this search

|
1. Report from Session III of the Second International Colloquium on Cardio-oncology: Cardio-oncological management of patients. [Review]

by Barac, Ana.

Published: 2019; ; Citation: Seminars in Oncology. 46(6):408-413, 2019 12.; .Institution: MedStar Heart & Vascular Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Barac A; Cardinale DM; Khandheria BK; Lenihan D; Minotti G; Torbicki A.UI/PMID: 31784042.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1053/j.seminoncol.2019.11.002 (Click here)
2. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

by Rao, Suman.

Published: 2019; ; Citation: Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.; .Institution: Medstar Franklin Square Medical Center.Publication: Journal Article.Article type: Journal Article.Full author list: Brahmer JR; Csoszi T; Cuffe S; Fulop A; Gottfried M; Hotta K; Hui R; O'Brien M; Peled N; Pietanza MC; Rao S; Reck M; Riccio A; Robinson AG; Rodriguez-Abreu D; Tafreshi A; Vandormael K; Yang J.UI/PMID: 30620668.Digital Object Identifier: https://dx.doi.org/10.1200/JCO.18.00149 (Click here)
3. Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma

by Narkhede, Mayur; Sarraf Yazdy, Maryam.

Published: ; 2018Citation: Expert Review of Hematology. 11(10):773-780, 2018 10..Institution: MedStar Washington Hospital Center.Department: Hematology and Oncology.Publication: Journal Article.Article type: Journal Article.Full author list: Narkhede M; Sarraf Yazdy M; Cheson B.UI/PMID: 30139285.Digital Object Identifier: https://dx.doi.org/10.1080/17474086.2018.1516135 (Click here)
4. Radioiodine refractory differentiated thyroid cancer. [Review]

by Van Nostrand, Douglas.

Published: 2018Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May..Institution: MedStar Washington Hospital Center.Department: Medicine/Nuclear Medicine.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L.UI/PMID: 29650270.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 (Click here)
5. A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL

by Trivedi, Neel.

Published: 2018Citation: Blood Advances. 2(7):762-768, 2018 Apr 10.Institution: MedStar Washington Hospital Center.Department: Hematology and Oncology.Publication: Journal Article.Article type: Journal Article.Full author list: Ujjani C; Wang H; Skarbnik A; Trivedi N; Ramzi P; Khan N; Cheson BD.UI/PMID: 29610115.Digital Object Identifier: https://dx.doi.org/10.1182/bloodadvances.2017015263 (Click here)
6. Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients

by Sugarbaker, Paul H.

Published: ; 2018Citation: Annals of Surgical Oncology. 25(4):1094-1100, 2018 Apr..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Mercier F; Passot G; Villeneuve L; Levine EA; Yonemura Y; Goere D; Sugarbaker PH; Marolho C; Bartlett DL; Glehen O; PSOGI and BIG RENAPE Groups.UI/PMID: 29238881.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1245/s10434-017-6299-z (Click here)
7. Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

by Swain, Sandra M; McCarron, Edward C.

Published: 2018Citation: Journal of the National Cancer Institute. 110(2), 2018 Feb 01.Institution: Washington Cancer Institute; MedStar Franklin Square Medical Center.Publication: Journal Article.Article type: Journal Article.Full author list: Bandos H; Melnikow J; Rivera DR; Swain SM; Sturtz K; Fehrenbacher L; Wade JL 3rd; Brufsky AM; Julian TB; Margolese RG; McCarron EC; Ganz PA.UI/PMID: 28954297.Digital Object Identifier: https://dx.doi.org/10.1093/jnci/djx162 (Click here)
8. DA-EPOCH-R for post-transplant lymphoproliferative disorders

by DeStefano, Christin B; Malkovska, Vera; Shenoy, Aarthi; Fitzpatrick, Kelly; Catlett, Joseph.

Published: 2017Citation: European Journal of Haematology. 99(3):283-285, 2017 Sep..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Case Reports.Full author list: DeStefano CB; Malkovska V; Rafei H; Shenoy A; Fitzpatrick K; Aggarwal A; Catlett JP.UI/PMID: 28509395.Digital Object Identifier: https://dx.doi.org/10.1111/ejh.12904 (Click here)
9. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

by Cruz, Allan-Louie.

Published: 2017Citation: Annals of Oncology. 28(5):1050-1056, 2017 May 01.Institution: MedStar Washington Hospital Center.Department: Hematology/Oncology.Publication: Journal Article.Article type: Journal Article.Full author list: Mato AR; Hill BT; Lamanna N; Barr PM; Ujjani CS; Brander DM; Howlett C; Skarbnik AP; Cheson BD; Zent CS; Pu JJ; Kiselev P; Foon K; Lenhart J; Henick Bachow S; Winter AM; Cruz AL; Claxton DF; Goy A; Daniel C; Isaac K; Kennard KH; Timlin C; Fanning M; Gashonia L; Yacur M; Svoboda J; Schuster SJ; Nabhan C.UI/PMID: 28453705.Digital Object Identifier: https://dx.doi.org/10.1093/annonc/mdx031 (Click here)
10. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

by Swain, Sandra M.

Published: 2017Citation: Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb.Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Smith JW 2nd; Buyse ME; Rastogi P; Geyer CE Jr; Jacobs SA; Patocskai EJ; Robidoux A; Conlin AK; Ansari B; Keogh GP; Stella PJ; Gross HM; Lord RS; Polikoff JA; Mauquoi C; Mamounas EP; Swain SM; Wolmark N.UI/PMID: 27693116.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.clbc.2016.07.008 (Click here)
11. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. [Review]

by Sugarbaker, Paul H.

Published: 2016Citation: European Journal of Surgical Oncology. 42(8):1123-31, 2016 Aug.Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H.UI/PMID: 27160355.Online Access: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.ejso.2016.03.016 (Click here)
12. Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer: A Systematic Literature Review. [Review]

by Sugarbaker, Paul H.

Published: 2016Citation: International Journal of Gynecological Cancer. 26(4):661-70, 2016 May.Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Hotouras A; Desai D; Bhan C; Murphy J; Lampe B; Sugarbaker PH.UI/PMID: 26844612.Digital Object Identifier: https://dx.doi.org/10.1097/IGC.0000000000000664 (Click here)
13. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome

by Ihemelandu, Chukwuemeka; Bijelic, Lana; Sugarbaker, Paul H.

Citation: Annals of Surgical Oncology. 22(5):1680-5, 2015 May..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article.Full author list: Ihemelandu C; Bijelic L; Sugarbaker PH.UI/PMID: 25120250.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1245/s10434-014-3977-y (Click here)
14. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

by Kumar, Anjali S.

Citation: Lancet Oncology. 16(8):957-66, 2015 Aug..Institution: MedStar Washington Hospital Center.Department: Surgery/Colorectal Surgery.Publication: Journal Article.Article type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural.Full author list: Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K; Timing of Rectal Cancer Response to Chemoradiation Consortium.UI/PMID: 26187751.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 (Click here)
15. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

by Swain, Sandra M.

Citation: Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Perez EA; Romond EH; Suman VJ; Jeong JH; Sledge G; Geyer CE Jr; Martino S; Rastogi P; Gralow J; Swain SM; Winer EP; Colon-Otero G; Davidson NE; Mamounas E; Zujewski JA; Wolmark N.UI/PMID: 25332249.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2014.55.5730 (Click here)
16. Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. [Review]

by Sugarbaker, Paul H.

Citation: World Journal of Gastroenterology. 20(28):9286-91, 2014 Jul 28..Institution: MedStar Washington Hospital Center.Department: Surgery/General Surgery.Publication: Journal Article.Full author list: Sugarbaker PH.UI/PMID: 25071322.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.3748/wjg.v20.i28.9286 (Click here)
17. Treatment of HER2-positive metastatic breast cancer

by Swain, Sandra M.

Citation: New England Journal of Medicine. 372(20):1964-5, 2015 May 14..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Comment; Letter.Full author list: Swain SM; Clark E; Baselga J.UI/PMID: 25970056.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1056/NEJMc1503446 (Click here)
18. Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA

by Swain, Sandra M.

Citation: Oncologist. 19(7):693-701, 2014 Jul..Institution: Washington Cancer Institute.Publication: Journal Article.Full author list: Swain SM; Im YH; Im SA; Chan V; Miles D; Knott A; Clark E; Ross G; Baselga J.UI/PMID: 24869931.Digital Object Identifier: http://dx.doi.org/10.1634/theoncologist.2014-0033 (Click here)
19. Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review. [Review]

by Verma, Nitin.

Citation: International Journal of Urology. 21(7):630-7, 2014 Jul..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Review.Full author list: Sio TT; Ko J; Gudena VK; Verma N; Chaudhary UB.UI/PMID: 24455982.Digital Object Identifier: http://dx.doi.org/10.1111/iju.12407 (Click here)
20. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

by Swain, Sandra M.

Citation: New England Journal of Medicine. 372(8):724-34, 2015 Feb 19..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Swain SM; Baselga J; Kim SB; Ro J; Semiglazov V; Campone M; Ciruelos E; Ferrero JM; Schneeweiss A; Heeson S; Clark E; Ross G; Benyunes MC; Cortes J; CLEOPATRA Study Group.UI/PMID: 25693012.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1056/NEJMoa1413513 (Click here)
21. Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA

by Swain, Sandra M.

Citation: Annals of Oncology. 25(6):1116-21, 2014 Jun..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Swain SM; Baselga J; Miles D; Im YH; Quah C; Lee LF; Cortes J.UI/PMID: 24685829.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdu133 (Click here)
22. Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer

by Van Echo, David A.

Citation: Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 9(1):121-5, 2014 Jan..Institution: MedStar Health Research Institute.Publication: Journal Article.Article type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't.Full author list: Chiappori A; Williams C; Northfelt DW; Adams JW; Malik S; Edelman MJ; Rosen P; Van Echo DA; Berger MS; Haura EB.UI/PMID: 24346101.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1097/JTO.0000000000000027 (Click here)
23. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. [Review]

by Swain, Sandra M.

Citation: Lancet. 384(9938):164-72, 2014 Jul 12..Publication: Journal Article.Article type: Journal Article; Meta-Analysis; Research Support, U.S. Gov't, P.H.S.; Review.Full author list: Cortazar P; Zhang L; Untch M; Mehta K; Costantino JP; Wolmark N; Bonnefoi H; Cameron D; Gianni L; Valagussa P; Swain SM; Prowell T; Loibl S; Wickerham DL; Bogaerts J; Baselga J; Perou C; Blumenthal G; Blohmer J; Mamounas EP; Bergh J; Semiglazov V; Justice R; Eidtmann H; Paik S; Piccart M; Sridhara R; Fasching PA; Slaets L; Tang S; Gerber B; Geyer CE Jr; Pazdur R; Ditsch N; Rastogi P; Eiermann W; von Minckwitz G.UI/PMID: 24529560.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(13)62422-8 (Click here)
24. Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

by Swain, Sandra M.

Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Miles D; Baselga J; Amadori D; Sunpaweravong P; Semiglazov V; Knott A; Clark E; Ross G; Swain SM.UI/PMID: 24129974.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1007/s10549-013-2710-z (Click here)
25. Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer

by Swain, Sandra M.

Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Cortes J; Baselga J; Im YH; Im SA; Pivot X; Ross G; Clark E; Knott A; Swain SM.UI/PMID: 23868905.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdt274 (Click here)
26. Reply to E.J. Moylan et al

by Swain, Sandra M.

Citation: Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Comment; Letter.Full author list: Swain SM; Tang G; Geyer CE Jr.UI/PMID: 24419136.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2013.53.8744 (Click here)
27. Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel

by Swain, Sandra M.

Citation: Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Research Support, Non-U.S. Gov't.Full author list: Cortes J; Swain SM; Kudaba I; Hauschild M; Patel T; Grincuka E; Masuda N; McNally V; Ross G; Brewster M; Marier JF; Trinh MM; Garg A; Nijem I; Visich J; Lum BL; Baselga J.UI/PMID: 23969513.Digital Object Identifier: http://dx.doi.org/10.1097/CAD.0000000000000016 (Click here)
28. Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

by Swain, Sandra M.

Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Robidoux A; Tang G; Rastogi P; Geyer CE Jr; Azar CA; Atkins JN; Fehrenbacher L; Bear HD; Baez-Diaz L; Sarwar S; Margolese RG; Farrar WB; Brufsky AM; Shibata HR; Bandos H; Paik S; Costantino JP; Swain SM; Mamounas EP; Wolmark N.UI/PMID: 24095300.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(13)70411-X (Click here)
29. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

by Swain, Sandra M.

Citation: Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural.Full author list: Swain SM; Tang G; Geyer CE Jr; Rastogi P; Atkins JN; Donnellan PP; Fehrenbacher L; Azar CA; Robidoux A; Polikoff JA; Brufsky AM; Biggs DD; Levine EA; Zapas JL; Provencher L; Northfelt DW; Paik S; Costantino JP; Mamounas EP; Wolmark N.UI/PMID: 23940225.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2012.48.1275 (Click here)
30. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005)

by Priebat, Dennis A.

Citation: Cancer. 119(8):1555-61, 2013 Apr 15..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't.Full author list: Hensley ML; Wathen JK; Maki RG; Araujo DM; Sutton G; Priebat DA; George S; Soslow RA; Baker LH.UI/PMID: 23335221.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1002/cncr.27942 (Click here)
31. Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study

by Swain, Sandra M.

Citation: Oncologist. 18(3):257-64, 2013..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Swain SM; Ewer MS; Cortes J; Amadori D; Miles D; Knott A; Clark E; Benyunes MC; Ross G; Baselga J.UI/PMID: 23475636.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1634/theoncologist.2012-0448 (Click here)
32. Avastin withdrawal symptoms

by Lynce, Filipa; Swain, Sandra M.

Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Editorial; Research Support, Non-U.S. Gov't.Full author list: Lynce F; Swain SM.UI/PMID: 22263961.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1517/14656566.2012.652088 (Click here)
33. Avoiding a throwback to the past

by Sugarbaker, Paul H.

Published: 2013Citation: Journal of Clinical Oncology. 31(3):396-7, 2013 Jan 20..Institution: MedStar Washington Hospital Center.Department: Surgery/General Surgery.Publication: Journal Article.Article type: Comment; Letter.Full author list: Sugarbaker PH.UI/PMID: 23269997.Online Access: Click here to access online Digital Object Identifier: (Click here)
34. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

by Sugarbaker, Paul H; Yan, Tristan D.

Citation: Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10..Institution: MedStar Washington Hospital Center; Washington Cancer Institute.Department: Surgery/General Surgery.Publication: Journal Article.Article type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't.Full author list: Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gomez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; Gonzalez-Moreno S; Van Der Speeten K; Morris DL.UI/PMID: 22614976.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1200/JCO.2011.39.7166 (Click here)
35. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

by Swain, Sandra M.

Published: 2013Citation: Lancet Oncology. 14(6):461-71, 2013 May..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't.Full author list: Baselga J; Benyunes MC; Campone M; Ciruelos E; Clark E; Cortes J; Ferrero JM; Kim SB; Knott A; Ro J; Ross G; Schneeweiss A; Semiglazov V; Swain SM.UI/PMID: 23602601.Online Access: Click here to access online Digital Object Identifier: (Click here)
36. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

by Swain, Sandra M.

Citation: Lancet. 379(9814):432-44, 2012 Feb 4..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't.Full author list: Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Peto R; Davies C; Godwin J; Gray R; Pan HC; Clarke M; Cutter D; Darby S; McGale P; Taylor C; Wang YC; Bergh J; Di Leo A; Albain K; Swain S; Piccart M; Pritchard K.UI/PMID: 22152853.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(11)61625-5 (Click here)
37. Bevacizumab added to neoadjuvant chemotherapy for breast cancer

by Swain, Sandra M.

Citation: New England Journal of Medicine. 366(4):310-20, 2012 Jan 26..Institution: Washington Cancer Institute.Publication: Journal Article.Article type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S..Full author list: Bear HD; Tang G; Rastogi P; Geyer CE Jr; Robidoux A; Atkins JN; Baez-Diaz L; Brufsky AM; Mehta RS; Fehrenbacher L; Young JA; Senecal FM; Gaur R; Margolese RG; Adams PT; Gross HM; Costantino JP; Swain SM; Mamounas EP; Wolmark N.UI/PMID: 22276821.Online Access: Click here to access online Digital Object Identifier: http://dx.doi.org/10.1056/NEJMoa1111097 (Click here)

Powered by Koha